Ran Wei
- Biomaterials top 2%
- Supramolecular Self-Assembly in Materials 6
- Immunology top 5%
- Immune cells in cancer 9
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 10
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 8
- Cancer Research top 10%
-
- Radiomics and Machine Learning in Medical Imaging 12
-
- RNA modifications and cancer 8
-
- Thyroid Cancer Diagnosis and Treatment 7
-
- Ferroptosis and cancer prognosis 6
- Journals
- Scientific Reports (5 papers)European Journal of Medicinal Chemistry (5 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ran Wei
85 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 129
- Biomaterials 650
- Immunology 616
- Biomedical Engineering 1.0k
- Oncology 514
- Cancer Research 263
Countries citing papers authored by Ran Wei
This map shows the geographic impact of Ran Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Wei more than expected).
Fields of papers citing papers by Ran Wei
This network shows the impact of papers produced by Ran Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Wei. The network helps show where Ran Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ran Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 24 | |
| 9 | 2022 | 28 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 23 | |
| 13 | 2021 | 15 | |
| 14 | 2021 | 20 | |
| 15 | 2020 | 60 | |
| 16 | 2019 | 1 | |
| 17 | 2018 | 8 | |
| 18 | 2017 | 56 | |
| 19 | 2015 | 53 | |
| 20 | 2011 | 15 |
About Ran Wei
Ran Wei is a scholar working on Cancer Research, Biomaterials, Oncology, Health Informatics and Immunology, having authored 92 papers that have together received 2.7k indexed citations. Recurring topics across this work include Radiomics and Machine Learning in Medical Imaging (12 papers), Nanoplatforms for cancer theranostics (10 papers), Immune cells in cancer (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), RNA modifications and cancer (8 papers), Thyroid Cancer Diagnosis and Treatment (7 papers), Ferroptosis and cancer prognosis (6 papers) and Supramolecular Self-Assembly in Materials (6 papers). The work is most often cited by research in Biomaterials (650 citations), Immunology (616 citations), Biomedical Engineering (1.0k citations), Oncology (514 citations) and Cancer Research (263 citations). Ran Wei has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yaping Li, Pengcheng Zhang, Yihui Zhai, Qi Yin, Meng Jia, Haijun Yu, Zhiwen Zhang, Tianqun Lang, Jinghan Su and Chunhua Hu. Their work appears in journals such as Scientific Reports, European Journal of Medicinal Chemistry, Oncotarget, Advanced Functional Materials and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.